Akoya Biosciences, Inc.

Akoya Biosciences, Inc.

Biotechnology Research

Marlborough, Massachusetts 33,488 followers

Bringing context to biology and human health through spatial phenotyping — we are The Spatial Biology Company®. 🥼🧬

About us

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode™ Panels, PhenoCycler®, PhenoImager® Fusion, and PhenoImager HT Instruments. View our open job descriptions: www.akoyabio.com/careers Follow us on Twitter: www.twitter.com/AkoyaBio Subscribe to our YouTube channel: www.youtube.com/c/AkoyaBiosciences

Website
akoyabio.com/tour-2024
Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
Marlborough, Massachusetts
Type
Public Company
Founded
2015
Specialties
multiplex IHC, spatial biology, digital pathology, immunofluorescence, immunohistochemistry, immuno-oncology, multispectral imaging, tissue analysis, multiplexed biomarker analysis, whole slide scanning, multiplex imaging, single cell , and spatial phenotyping

Locations

  • Primary

    100 Campus Dr

    6th Floor

    Marlborough, Massachusetts 01752, US

    Get directions

Employees at Akoya Biosciences, Inc.

Updates

  • Akoya Biosciences, Inc. reposted this

    What it is: The Akoya Biosciences PhenoCycler-Fusion 1.0 instrument When it was acquired: October 2023 Where it is: Jimmy Fund Building, 2nd Floor What it does: This microscopic imaging system enables pathologists to see up to 100 molecular biomarkers across every cell in a tumor sample on a single slide, letting them visualize which molecules are in each cell and where they are across the entire tissue sample. This wealth of information reveals how the tissue is organized and provides a nuanced understanding to better diagnose and treat the disease. How it works: Research scientist Namrata Singh, PhD, uses the instrument's microfluidic system to apply a cocktail of up to 40 antibodies to a tissue sample slide. Each antibody binds to an antigen that is a unique portion of a biomarker of interest. She then uses the system to add antibody-specific fluorescent color-coded reporters, which glow with a distinct color to signal the presence of a particular biomarker. Using the system, these signals are revealed and imaged. The antibodies and reporters are then removed by the system in preparation for another cocktail. During imaging, the slide lights up with fluorescent colors, indicating the presence and location of the biomarkers. Singh can switch signals on and off, for instance, to focus on immune biomarkers or examine biomarkers that indicate a specific type, stage, or feature of the cancer. “When I first saw the Phenocycler images, I felt so emotional,” says Singh. “It’s just... I’m having goosebumps right now. You can clearly see not only the tumor but also the tumor microenvironment and how the disease is behaving.” What it is used for: Traditional methods for revealing biomarkers can only reveal two or three at a time. This system can show up to 100, which enables researchers to learn more about how cancer and its surrounding tissues interact with and respond to treatments. Special services for scientists: Singh uses the instrument to support researchers who want to learn more about tissue samples they've collected as part of a study. She can help researchers create custom antibodies to look at markers that have not been studied before. Fun fact: The substances used to create the slide stain cocktails are stored in what Singh calls her “deli fridge” because it looks like a fridge of sodas in a delicatessen.

    • No alternative text description for this image
  • 🚨 𝐓𝐨𝐝𝐚𝐲 𝐢𝐬 𝐭𝐡𝐞 𝐋𝐀𝐒𝐓 𝐝𝐚𝐲 𝐭𝐨 𝐚𝐩𝐩𝐥𝐲!  🚨 Don’t miss your chance to take part in the 𝐈𝐎𝟔𝟎 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐎𝐦𝐢𝐜𝐬 𝐆𝐫𝐚𝐧𝐭 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 and advance your research with cutting-edge 𝐬𝐩𝐚𝐭𝐢𝐚𝐥 𝐩𝐫𝐨𝐭𝐞𝐨𝐦𝐢𝐜𝐬 on the 𝐏𝐡𝐞𝐧𝐨𝐂𝐲𝐜𝐥𝐞𝐫®-𝐅𝐮𝐬𝐢𝐨𝐧 𝟐.𝟎 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦. Apply now to unlock a 60-marker spatial phenotyping dataset and collaborate with Akoya experts to push the boundaries of your genomics and transcriptomics studies. 👉 Apply Here: https://lnkd.in/eHJzupXd ⏳ Applications close TODAY, December 13, 2024!

    View organization page for Akoya Biosciences, Inc., graphic

    33,488 followers

    𝐓𝐡𝐞 𝐈𝐎𝟔𝟎 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐎𝐦𝐢𝐜𝐬 𝐆𝐫𝐚𝐧𝐭 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 – 𝟐 𝐃𝐚𝐲𝐬 𝐋𝐞𝐟𝐭 𝐭𝐨 𝐀𝐩𝐩𝐥𝐲!  We’re thrilled to offer this game-changing opportunity to elevate your research with cutting-edge spatial proteomics on the PhenoCycler®-Fusion 2.0 platform. 💡 𝐖𝐡𝐚𝐭’𝐬 𝐢𝐧 𝐢𝐭 𝐟𝐨𝐫 𝐲𝐨𝐮?  ✅ A comprehensive 60-marker spatial phenotyping dataset tailored to your research. ✅ Expert guidance from Akoya’s spatial biology team to supercharge your genomics and transcriptomics studies. 𝐃𝐨𝐧’𝐭 𝐰𝐚𝐢𝐭—seize this moment to push the boundaries of your research! 📅 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 𝟏𝟑𝐭𝐡 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟒 Learn more and apply today! https://lnkd.in/eHJzupXd 𝐍𝐞𝐞𝐝 𝐈𝐧𝐬𝐩𝐢𝐫𝐚𝐭𝐢𝐨𝐧? Join our 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐎𝐦𝐢𝐜𝐬 𝐅𝐫𝐨𝐧𝐭𝐢𝐞𝐫𝐬 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐒𝐞𝐫𝐢𝐞𝐬. Hear from leading experts in spatial biology as they share how they are integrating spatial technologies for a comprehensive, multi-analyte approach. https://lnkd.in/eZxpY2QC #SpatialProteomics #Genomics #Transcriptomics #ResearchGrant #AkoyaBiosciences

    • No alternative text description for this image
  • Akoya Biosciences, Inc. reposted this

    Last week at #Multiomics2024 in Brisbane, we had the opportunity to re-unite with the researchers from the spatial community and hear from Niro Ramachandran on Akoya’s exciting new product launch including IO-60 panel and our clinical vision in the coming years. What a fantastic conference led by Arutha Kulasinghe! We even hosted a round-the-table discussion amongst our PhenoCycler-Fusion users from Australia to foster collaboration and strengthen the largest spatial proteomics community in the country. #spatialbiology #akoyabiosciences #geneworks #multiomics2024 #spatialproteomicscommunity

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • 𝐓𝐡𝐞 𝐈𝐎𝟔𝟎 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐎𝐦𝐢𝐜𝐬 𝐆𝐫𝐚𝐧𝐭 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 – 𝟐 𝐃𝐚𝐲𝐬 𝐋𝐞𝐟𝐭 𝐭𝐨 𝐀𝐩𝐩𝐥𝐲!  We’re thrilled to offer this game-changing opportunity to elevate your research with cutting-edge spatial proteomics on the PhenoCycler®-Fusion 2.0 platform. 💡 𝐖𝐡𝐚𝐭’𝐬 𝐢𝐧 𝐢𝐭 𝐟𝐨𝐫 𝐲𝐨𝐮?  ✅ A comprehensive 60-marker spatial phenotyping dataset tailored to your research. ✅ Expert guidance from Akoya’s spatial biology team to supercharge your genomics and transcriptomics studies. 𝐃𝐨𝐧’𝐭 𝐰𝐚𝐢𝐭—seize this moment to push the boundaries of your research! 📅 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 𝟏𝟑𝐭𝐡 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟒 Learn more and apply today! https://lnkd.in/eHJzupXd 𝐍𝐞𝐞𝐝 𝐈𝐧𝐬𝐩𝐢𝐫𝐚𝐭𝐢𝐨𝐧? Join our 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐎𝐦𝐢𝐜𝐬 𝐅𝐫𝐨𝐧𝐭𝐢𝐞𝐫𝐬 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐒𝐞𝐫𝐢𝐞𝐬. Hear from leading experts in spatial biology as they share how they are integrating spatial technologies for a comprehensive, multi-analyte approach. https://lnkd.in/eZxpY2QC #SpatialProteomics #Genomics #Transcriptomics #ResearchGrant #AkoyaBiosciences

    • No alternative text description for this image
  • Exciting News in Immuno-Oncology Research! We are excited to announce that Propath UK, a leading Contract Research Organization (CRO) specializing in molecular pathology and spatial biology, and one of our qualified service providers, is the first CRO in Europe to offer the newly launched PhenoCode Discovery IO60 Panel.   This groundbreaking ultrahigh-plex panel is designed to accelerate insights and empower researchers offering a fast and comprehensive approach to immuno-oncology discovery. Propath UK's comprehensive service covers every step of the process, from expert tissue pre-processing, to staining and imaging with the Akoya Biosciences, Inc. PhenoCycler-Fusion Service, to offer a complete data analysis solution.   Come and join both Akoya Biosciences (Booth #32) and ProPath (Booth #55) at the Digital Pathology and AI Congress in London (11-12 December 2024) to learn more and explore how these innovations can elevate your research. #DigiPathLondon #TheSpatialBiologyCompany #PhenoCodeIO60 #PhenoCyclerFusion

    • No alternative text description for this image
  • 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐢𝐬 𝐍𝐨𝐰 𝐚 𝐑𝐞𝐚𝐥𝐢𝐭𝐲! We are excited to announce that Akoya Biosciences and NeraCare have entered into an exclusive global license agreement to develop and commercialize the groundbreaking Immunoprint Test for early-stage melanoma treatment decisions. 𝐖𝐡𝐲 𝐈𝐭 𝐌𝐚𝐭𝐭𝐞𝐫𝐬: Every year, over 235,000 new cases of melanoma are diagnosed, with 80% in early stages. These patients are often ineligible for therapies designed for advanced disease. The Immunoprint Test addresses this unmet need by identifying early-stage melanoma patients at high risk of recurrence — unlocking access to potentially life-saving treatments. 𝐖𝐡𝐚𝐭’𝐬 𝐍𝐞𝐱𝐭: By integrating Immunoprint with our market-leading PhenoImager HT platform, this partnership combines NeraCare’s innovative assay with Akoya’s cutting-edge spatial biology technology. Together, we’re driving earlier therapeutic interventions and providing tools to guide better treatment decisions for patients worldwide. 📢 𝐓𝐡𝐞 𝐞𝐫𝐚 𝐨𝐟 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐢𝐬 𝐡𝐞𝐫𝐞 — and we’re transforming the future of melanoma care. 👉 Learn more: https://lnkd.in/gZ9Wts_z #AkoyaBiosciences #NeraCare #MelanomaCare #SpatialBiology #SpatialMedicine #Innovation #LifeSciences #Immunoprint

    • No alternative text description for this image
  • 𝐃𝐨𝐧’𝐭 𝐌𝐢𝐬𝐬 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐒𝐞𝐬𝐬𝐢𝐨𝐧! 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐏𝐫𝐨𝐭𝐞𝐨𝐦𝐢𝐜𝐬: 𝐌𝐞𝐭𝐡𝐨𝐝 𝐨𝐟 𝐭𝐡𝐞 𝐘𝐞𝐚𝐫 𝟐𝟎𝟐𝟒 is redefining discovery, and we’re diving deep into how it’s transforming research at the intersection of spatial transcriptomics and proteomics, powered by AI-driven analytics. 🎤 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐒𝐩𝐞𝐚𝐤𝐞𝐫: Kevin Matthew Byrd, DDS, PhD Associate Professor, Virginia Commonwealth University Dr. Byrd will showcase cutting-edge research mapping key hubs and functional modules within tissues, offering unparalleled insights into RNA and protein landscapes. This revolutionary approach is advancing our understanding of tissue dynamics and unlocking new perspectives on disease mechanisms. Be part of the conversation that’s reshaping science with the Method of the Year! 🗓 Date: Tuesday, December 10, 2024 🕘 Time: 9 AM PST | 12 PM EST | 5 PM GMT 👉 Register Now to join the future of spatial omics: 🔗 Register Here: https://lnkd.in/guyZnQdP 🔗 Explore the Spatial Omics Frontier Series: https://lnkd.in/eZxpY2QC 🔗 Apply for the IO60 Spatial Omics Grant:https://lnkd.in/eHJzupXd Celebrate and explore the science behind Method of the Year 2024 and beyond! 🌟 #SpatialProteomics #MethodOfTheYear #Proteomics #SpatialOmics #PhenoCyclerFusion #TheSpatialBiologyCompany

    • No alternative text description for this image
  • 🌟 Spatial Proteomics: Nature's Method of the Year 2024! 🌟 At Akoya, we are excited to celebrate Nature’s Method of the Year 2024: Spatial Proteomics! This groundbreaking field is revolutionizing biology by transforming how we map biological complexity, connecting structure and function across cells, tissues, and organs. With cutting-edge tools like PhenoCycler-Fusion and PhenoImager HT, alongside global initiatives like HuBMAP and HTAN, spatial proteomics is turning the promise of unraveling health and disease at the protein level into reality. Backed by over 1,500 publications, we stand on the shoulders of giants, proud to help propel this transformative field forward. As the leader in spatial biology, Akoya is at the forefront of innovation, driving progress in multiplexing, AI, and multi-omics integration to push the boundaries of discovery and precision medicine. Here’s to a future rich in biological insight and groundbreaking innovation. 🎉 Let’s build the atlas of tomorrow, together! https://lnkd.in/epNmXHh9 #SpatialProteomics #NatureMethodOfTheYear #SpatialBiology #Proteomics #Innovation

    • No alternative text description for this image
  • 𝐖𝐞 𝐀𝐫𝐞 𝐇𝐞𝐚𝐝𝐞𝐝 𝐭𝐨 𝐭𝐡𝐞 𝐒𝐩𝐚𝐭𝐢𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐔𝐒 𝐖𝐞𝐬𝐭 𝐂𝐨𝐚𝐬𝐭 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞! We’re excited to share that Cameron Smurthwaite MSc, MBA from our team will be presenting at this incredible event! 📢 Don’t miss his talk: 𝑹𝒆𝒗𝒐𝒍𝒖𝒕𝒊𝒐𝒏𝒊𝒛𝒊𝒏𝒈 𝑺𝒑𝒂𝒕𝒊𝒂𝒍 𝑩𝒊𝒐𝒍𝒐𝒈𝒚: 𝑴𝒐𝒍𝒆𝒄𝒖𝒍𝒂𝒓 𝑩𝒂𝒓𝒄𝒐𝒅𝒊𝒏𝒈 𝒂𝒏𝒅 𝒎𝑰𝑭 𝒇𝒐𝒓 𝑷𝒓𝒆𝒄𝒊𝒔𝒊𝒐𝒏 𝑴𝒆𝒅𝒊𝒄𝒊𝒏𝒆 Cameron will showcase how Akoya’s PhenoCycler-Fusion 2.0 and PhenoImager HT 2.0 are advancing ultrahigh-plex spatial discoveries and enabling rapid spatial signature development—transforming precision medicine and clinical trial outcomes. 🗓 When: Thursday, December 5th, 2 PM 📍 Track: Applications of Spatial Research & Technologies in Biology We can’t wait to connect with the spatial biology community and share how our technologies are shaping the future of drug discovery and clinical applications. 👉 Planning to attend? Be sure to check out Cameron’s talk and meet us during the conference! Haven’t registered yet? Secure your spot here: https://lnkd.in/exdXKdJW #AkoyaBiosciences #SpatialBiology #PrecisionMedicine #PhenoCyclerFusion #PhenoImagerHT #TeamAkoya

    • No alternative text description for this image

Similar pages

Browse jobs

Funding

Akoya Biosciences, Inc. 4 total rounds

Last Round

Post IPO equity

US$ 43.5M

See more info on crunchbase